Confinement and Spondyloarthritis Treatment

• Conditions: Spondyloarthritis

• Registration Number: NCT04355923
• Lead Sponsor: Centre Hospitalier Universitaire de Nice

Brief Summary

Evaluate the impact of confinement on treatment use in spondyloarthritis. Study hypothesis that with the confinement, subjects will stop their treatment. The main objective is to study the impact of confinement on treatment. And secondly to look for for specific psychological profile linked to the interruption of the treatment. the study population consists of patients with spondyloarthritis and belonging to a patient association (ACS). All patients over 18 are included. A mailing questionnaire will be send to all patients. data on diseases activity and treatment will be collected

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-04
• Study First Submitted: 2020-04-16
• Study Start: 2020-04-20
• Study First Submitted QC: 2020-04-20
• Study First Posted: 2020-04-21
• Last Update Submitted: 2020-05-12
• Last Update Posted: 2020-05-13
• Primary Completion: 2020-05-15
• Study Completion: 2020-05-15

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• spondyloarthritis,
• age over 18 ans
• treatment by NSAID or biological treatment to be part of the patient association "ACS" (action contre les spondylarthropathies).

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
treatment use	1 month	treatment continuation

Secondary Outcome Measures

Name	Time	Method
activity of disease	1 week	number of crisis
psychological aspects	1 month	quality of life questionnaire (EQ-5D) evaluating mobility, self care, usual activity, pain and anxiety

Trial Locations

Locations (1)

CHU de Nice; 🇫🇷 Nice, France